Research

Gender differences in the evolution of illness understanding among patients with advanced cancer

Although oncologist patient communication and shared decision making are increasingly recognized as important influences on EOL care, many advanced cancer patients do not accurately understand the severity of their illness.


 

Background Patient understanding of advanced metastatic disease is central to decisions about care near death. Prior studies have focused on gender differences in communication style rather than on illness understanding.

Objectives To evaluate gender differences in terminal illness acknowledgement (TIA), understanding that the disease is incurable and the advanced stage of the disease. To evaluate gender differences in patients’ reports of discussions of life expectancy with oncology providers and its effect on differences in illness understanding.

Methods Coping with Cancer 2 patients (N 68) were interviewed before and after a visit with their oncology providers to discuss scan results.

Results At the prescan interview, there were no statistically significant gender differences in patient measures of illness understanding. At the postscan interview, women were more likely than men to recognize that their illness was incurable (Adjusted Odds Ratio, [AOR] 5.29; P .038), know that their cancer was at an advanced stage (AOR, 6.38; P, .013), and report having had discussions of life expectancy with their oncologist (AOR, 4.77; P, .021). Controlling discussions of life expectancy, women were more likely than men to report that their cancer was at an advanced stage (AOR, 9.53; P .050). Controlling for gender, discussions of life expectancy were associated with higher rates of TIA (AOR, 4.65; P, .036) and higher rates of understanding that the cancer was incurable (AOR, 4.09; P .085).

Conclusions Due largely to gender differences in communication, women over time have a better understanding of their illness than men. More frequent discussions of life expectancy should enhance illness understanding and reduce gender differences.

*For a PDF of the full article, click on the link to the left of this introduction.

Recommended Reading

Practical considerations in the delivery of genetic counseling and testing services for inherited cancer predisposition
MDedge Hematology and Oncology
VTE rate triples in pediatric cancer survivors
MDedge Hematology and Oncology
Cancer survivors may have lower Alzheimer’s risk
MDedge Hematology and Oncology
Khorana score tracks risk of cancer death
MDedge Hematology and Oncology
Guidelines issued on radiation-induced heart disease
MDedge Hematology and Oncology
Oncologist compensation deserves evidence-based scrutiny and analysis
MDedge Hematology and Oncology
Few states meet palliative care benchmark
MDedge Hematology and Oncology
Best practices for pediatric palliative cancer care: a primer for clinical providers
MDedge Hematology and Oncology
Complementary and alternative medicine (CAM) use in advanced cancer: a systematic review
MDedge Hematology and Oncology
Chlorpromazine bioavailability from a topical gel formulation in volunteers
MDedge Hematology and Oncology